HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charalambos Andreadis Selected Research

romidepsin (FK228)

1/2020Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charalambos Andreadis Research Topics

Disease

14Neoplasms (Cancer)
11/2023 - 10/2005
13Lymphoma (Lymphomas)
12/2023 - 01/2005
9B-Cell Lymphoma (Lymphoma, B Cell)
11/2023 - 01/2019
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 04/2007
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2021 - 09/2008
5Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
04/2024 - 04/2010
4Disease Progression
01/2019 - 09/2008
4Renal Cell Carcinoma (Grawitz Tumor)
06/2012 - 03/2009
3Thrombosis (Thrombus)
04/2022 - 02/2016
2Hematologic Neoplasms (Hematological Malignancy)
07/2023 - 01/2020
2Cytokine Release Syndrome
10/2022 - 01/2019
2Multiple Myeloma
11/2021 - 01/2021
2Infections
10/2021 - 01/2005
2Urogenital Neoplasms
04/2016 - 01/2016
2Neoplasm Metastasis (Metastasis)
01/2016 - 01/2009
2Breast Neoplasms (Breast Cancer)
08/2012 - 01/2006
2Melanoma (Melanoma, Malignant)
05/2011 - 11/2008
2Adenocarcinoma
03/2006 - 01/2006
1Cognitive Dysfunction
11/2023
1Frailty
11/2023
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2023
1Weight Loss (Weight Reduction)
08/2023
1Venous Thromboembolism
04/2022
1Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2022
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022
1Neutropenia
10/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2021
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021
1Hemorrhage
01/2020
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2020
1Wounds and Injuries (Trauma)
01/2020
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2020
1Renal Insufficiency (Renal Failure)
01/2020
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2020
1Hodgkin Disease (Hodgkin's Disease)
01/2019
1Brain Edema (Cerebral Edema)
01/2019
1Bradycardia
01/2019
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019
1Hearing Loss (Hearing Impairment)
04/2016
1Heart Failure
04/2016
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2016
1Philadelphia Chromosome
01/2016
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2016
1Mucositis
06/2015
1Herpes Zoster
11/2014
1Pneumonia (Pneumonitis)
11/2014
1Splenomegaly
10/2014
1Osteonecrosis (Kienbock's Disease)
08/2012
1Head and Neck Neoplasms (Head and Neck Cancer)
08/2012
1Clear-cell metastatic renal cell carcinoma
03/2009

Drug/Important Bio-Agent (IBA)

9Chimeric Antigen ReceptorsIBA
11/2023 - 01/2019
7tisagenlecleucelIBA
04/2024 - 01/2019
5axicabtagene ciloleucelIBA
11/2023 - 01/2020
4Sunitinib (Sutent)FDA Link
06/2012 - 03/2009
3AnthracyclinesIBA
01/2020 - 01/2006
3Histone Deacetylases (Histone Deacetylase)IBA
01/2020 - 01/2017
3Histone Deacetylase InhibitorsIBA
01/2020 - 01/2017
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
04/2022 - 01/2020
2VaccinesIBA
11/2021 - 11/2014
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 01/2006
2Tyrosine Kinase InhibitorsIBA
01/2016 - 09/2010
2GemcitabineFDA Link
03/2006 - 01/2006
1Bendamustine HydrochlorideFDA Link
10/2023
1brexucabtagene autoleucelIBA
10/2023
1Brentuximab VedotinIBA
12/2022
1Tinzaparin (Innohep)FDA Link
04/2022
1EverolimusFDA Link
04/2022
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2021
1acalabrutinibIBA
01/2021
1Bevacizumab (Avastin)FDA Link
01/2020
1liposomal doxorubicin (Doxil)FDA Link
01/2020
1romidepsin (FK228)FDA Link
01/2020
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2019
1Immune Checkpoint InhibitorsIBA
01/2019
1PanobinostatIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1mocetinostatIBA
01/2017
1Histones (Histone)IBA
01/2017
1CreatinineIBA
04/2016
1Cisplatin (Platino)FDA LinkGeneric
04/2016
1vinflunineIBA
01/2016
1Etoposide (VP 16)FDA LinkGeneric
06/2015
1Busulfan (Busulfex)FDA Link
06/2015
1Diphosphonates (Bisphosphonates)IBA
08/2012
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2012
1Sorafenib (BAY 43-9006)FDA Link
06/2012
1AntibodiesIBA
05/2011
1Immunologic Factors (Immunomodulators)IBA
05/2011
1Brain Natriuretic Peptide (Natrecor)FDA Link
09/2010

Therapy/Procedure

19Therapeutics
12/2023 - 01/2006
5Cell Transplantation
11/2023 - 01/2016
5Drug Therapy (Chemotherapy)
09/2021 - 09/2005
3Hematopoietic Stem Cell Transplantation
01/2019 - 06/2015
2Induction Chemotherapy
10/2021 - 01/2019
2Stem Cell Transplantation
01/2019 - 06/2015
2Aftercare (After-Treatment)
09/2005 - 01/2005
1Kidney Transplantation
08/2023
1Palliative Care (Palliative Therapy)
07/2023
1Transplantation
01/2022
1Vena Cava Filters (Inferior Vena Cava Filter)
02/2016